Isabel is an Investment Associate focusing on the Life Sciences & Biosciences sector and provides support to Mercia’s portfolio companies.

Previous experience

Isabel has a range of experience in the drug development sector from early-stage research companies through to GMP manufacture and clinical trials. She holds a PhD in Molecular Virology and a degree in Biochemistry and Molecular Biology.